Catalyst Wire Dossier Catalyst Wire Dossier

Cirmtuzumab

cirmtuzumab
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Cirmtuzumab, covering 2024-10-09 to 2025-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax [Phase 2]

See pricing